SBL
EMN icon

Sargent Bickham Lagudis’s Eastman Chemical EMN Stock Holding History

Sargent Bickham Lagudis’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-49
Closed -$5K – 1066
2022
Q1 		$5K Hold
49
– – ﹤0.01% 792
2021
Q4 		$6K Buy
+49
New +$5.45K ﹤0.01% 773

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Sargent Bickham Lagudis's EMN Position: Q2 2022 in Review

Sargent Bickham Lagudis sold out of Eastman Chemical (EMN) in Q2 2022, closing a stake of 49 shares — an estimated $5K sold.

Sargent Bickham Lagudis first reported a position in EMN in Q4 2021 and held it in 2 quarters. The position peaked at $6K in Q4 2021. 688 funds tracked by Wall St. Rank hold EMN as of Q2 2022.

  • Sargent Bickham Lagudis reported no remaining Eastman Chemical position as of Q2 2022 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 49 Eastman Chemical shares in Q2 2022, an estimated $5K.
  • Sargent Bickham Lagudis first reported a position in Eastman Chemical in Q4 2021 and held it in 2 quarters.
  • Sargent Bickham Lagudis's Eastman Chemical position peaked at $6K in Q4 2021.
  • 688 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q2 2022, filed 13 Jul 2022.